找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Management of Hypertension; Current Practice and Vasilios Papademetriou,Emmanuel A. Andreadis,Chara Book 2019 Springer International Publis

[復(fù)制鏈接]
查看: 28751|回復(fù): 54
樓主
發(fā)表于 2025-3-21 18:55:38 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Management of Hypertension
副標(biāo)題Current Practice and
編輯Vasilios Papademetriou,Emmanuel A. Andreadis,Chara
視頻videohttp://file.papertrans.cn/623/622517/622517.mp4
概述There is no book about Hypertension with such a concept in the existing literature in the field.All the major hypertension trials discussed in a book – pros, cons, effects on international guidelines,
圖書封面Titlebook: Management of Hypertension; Current Practice and Vasilios Papademetriou,Emmanuel A. Andreadis,Chara Book 2019 Springer International Publis
描述.This book is a valuable tool to assist both cardiovascular physicians and scientists learning the intricacies of hypertension research and its milestone studies. All major hypertension trials have been reviewed in this book in chronological order with extensive?discussion of the study population, study design, and outcomes and with a special focus on what knowledge they offered, their strengths and weaknesses, statistical errors, impact on international guidelines and unmet needs.?Importantly, the book also offers physicians and young scientists with basic knowledge regarding medical biostatistics. It is of critical importance for a scientist involved in the field to understand deeply the process of analyzing medical data. Moreover, the accurate interpretation of the results is central for applying evidence-based medicine in everyday clinical practice...Management of Hypertension:?.Current Practice and the Application of Landmark Trials.?.is a critical tool to assist in the education of physicians and researchers in the field, providing a separate section on pioneer researchers in hypertension and urging readers to become bright exemplars for scientists wishing to pursue a career
出版日期Book 2019
關(guān)鍵詞Evidence based medicine; Hypertension; Landmark studies; Biostatistical weaknesses; Effect on Guidelines
版次1
doihttps://doi.org/10.1007/978-3-319-92946-0
isbn_ebook978-3-319-92946-0
copyrightSpringer International Publishing AG, part of Springer Nature 2019
The information of publication is updating

書目名稱Management of Hypertension影響因子(影響力)




書目名稱Management of Hypertension影響因子(影響力)學(xué)科排名




書目名稱Management of Hypertension網(wǎng)絡(luò)公開度




書目名稱Management of Hypertension網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Management of Hypertension被引頻次




書目名稱Management of Hypertension被引頻次學(xué)科排名




書目名稱Management of Hypertension年度引用




書目名稱Management of Hypertension年度引用學(xué)科排名




書目名稱Management of Hypertension讀者反饋




書目名稱Management of Hypertension讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 20:29:54 | 只看該作者
Arterial Hypertension: What Is the Optimal Goal of Treatment?, it reviews the MRC,the HDFP,the HOT, the SPRINT, the ACCORD and the HOPE-3 studies, and discusses the suggested optimal BP goals derived from these trials. It also focuses on interesting meta-analyses stratifying the different trials according to the BP levels achieved by active treatment.
板凳
發(fā)表于 2025-3-22 03:25:59 | 只看該作者
Comparison Therapies in the Treatment of Hypertension. The ASCOT and ACCOMPLISH Trial because few studies intended by design to compare two or more different combinations. ASCOT and ACCOMPLISH are considered the landmark trials in the comparison of combination therapies and had a great impact on hypertension guidelines and everyday clinical practice.
地板
發(fā)表于 2025-3-22 06:14:06 | 只看該作者
Advantages and Disadvantages in Clinical Trialstrials are essential in establishing the efficacy of pharmacologic and other interventions, but it may be difficult to make decisions on individual patients since the trials include large numbers of participants.
5#
發(fā)表于 2025-3-22 10:07:20 | 只看該作者
6#
發(fā)表于 2025-3-22 15:38:52 | 只看該作者
Book 2019one studies. All major hypertension trials have been reviewed in this book in chronological order with extensive?discussion of the study population, study design, and outcomes and with a special focus on what knowledge they offered, their strengths and weaknesses, statistical errors, impact on inter
7#
發(fā)表于 2025-3-22 18:59:34 | 只看該作者
8#
發(fā)表于 2025-3-23 00:57:29 | 只看該作者
9#
發(fā)表于 2025-3-23 02:16:40 | 只看該作者
The Life and the Major Scientific Contributions of Irvine Pageged mosaic theory of hypertension. In this chapter we discuss milestone moments in his life and scientific career, and we aim to offer to young scientists engaged in the cardiovascular field an insight into the personality and abilities of this great man, physician and researcher.
10#
發(fā)表于 2025-3-23 07:40:36 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 04:53
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
武乡县| 汕头市| 赣州市| 武定县| 大姚县| 丹阳市| 丁青县| 延安市| 新河县| 奉新县| 汤原县| 明溪县| 凌源市| 衡南县| 曲阜市| 滨州市| 咸宁市| 衢州市| 沭阳县| 安新县| 甘谷县| 宜良县| 长葛市| 方山县| 贺州市| 乾安县| 红河县| 东港市| 临沧市| 静安区| 邵东县| 儋州市| 扎鲁特旗| 玉屏| 淅川县| 都江堰市| 古交市| 彰化市| 承德市| 吴忠市| 青阳县|